UBS Adjusts Amgen (NASDAQ:AMGN) Price Target to $250 From $248By legume / July 24, 2023 / Amgen, UBS UBS Adjusts Amgen (NASDAQ:AMGN) Price Target to $250 From $248, Maintains Neutral Rating.